2026 Lipid Guidelines Beyond Statins:  Non- Statin Agents to Manage Dyslipidemias - Top-Institutions - MDSpire

2026 Lipid Guidelines Beyond Statins:  Non- Statin Agents to Manage Dyslipidemias

Dr. Talreja  discusses the 2026 standard of care for treatment of dyslipidemia with new screening guidelines and advanced therapy options.

  • June 12, 2026

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    NYU Langone Health
    NYU Langone Health

    New York, New York

    Key Differentiators

    • Cardiology

  • #2

    Mount Sinai Fuster Heart Hospital
    Mount Sinai Fuster Heart Hospital

    New York, New York

    Key Differentiators

    • Cardiology

Original Source(s)

2026 Lipid Guidelines Beyond Statins:  Non- Statin Agents to Manage Dyslipidemias

  • June 12, 2026

Related Content

Oral HRS-7535 Lowered A1c in Trial

Nonpeptide oral agent requires no fasting administration.

Triangulating evidence for cardiometabolic Index: ROC cutoff, spline nonlinearity, and explainable machine learning for CVD high risk

Effects of altitude and sociodemographic factors on cardiometabolic disorders in the southwestern plateau areas of China